Holen Sie sich die Stockscreener-App
54.85
9.70%
4.8936
Schlusskurs vom Vortag:
$49.96
Offen:
$54.09
24-Stunden-Volumen:
539.79K
Relative Volume:
0.50
Marktkapitalisierung:
$2.33B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-63.78M
KGV:
-20.47
EPS:
-2.68
Netto-Cashflow:
$-53.91M
1W Leistung:
+8.79%
1M Leistung:
+48.98%
6M Leistung:
+481.21%
1J Leistung:
+230.37%
1-Tages-Spanne:
$52.89
$55.25
1-Wochen-Bereich:
$48.73
$55.25
52-Wochen-Spanne:
$7.575
$55.25
Celcuity Inc Stock (CELC) Company Profile
Firmenname
Celcuity Inc
Sektor
Branche
Telefon
763-392-0767
Adresse
16305 36TH AVENUE N, MINNEAPOLIS, MN
Vergleichen Sie CELC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
54.87 | 2.10B | 0 | -63.78M | -53.91M | -2.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.04 | 99.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.36 | 62.21B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
455.00 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
704.37 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
302.00 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-01 | Fortgesetzt | Stifel | Buy |
| 2024-07-22 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-22 | Eingeleitet | Stifel | Buy |
| 2023-12-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-09-07 | Eingeleitet | Jefferies | Buy |
| 2021-07-29 | Eingeleitet | Cowen | Outperform |
| 2021-07-27 | Eingeleitet | Needham | Buy |
| 2021-01-28 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-11 | Fortgesetzt | Craig Hallum | Buy |
| 2018-11-20 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Celcuity Inc Aktie (CELC) Neueste Nachrichten
What to do if you’re stuck in Celcuity Inc.Earnings Miss & Community Driven Trade Alerts - Newser
Celcuity Shares Soar After FDA Accepts Gedatolisib NDA for Review - MSN
Is Celcuity Inc. showing signs of accumulationEarnings Overview Report & Long Hold Capital Preservation Plans - Newser
Celcuity Inc. stock momentum explainedMarket Risk Summary & Stepwise Trade Execution Plans - Newser
Using data filters to optimize entry into Celcuity Inc.July 2025 Selloffs & Smart Swing Trading Techniques - Newser
Will Celcuity Inc. bounce back from current support2025 Year in Review & Fast Gain Swing Trade Alerts - Newser
How to build a dashboard for Celcuity Inc. stockTreasury Yields & AI Powered Market Entry Ideas - Newser
Volume spikes in Celcuity Inc. stock – what they mean2025 Price Action Summary & Safe Swing Trade Setup Alerts - Newser
Smart tools for monitoring Celcuity Inc.’s price actionJuly 2025 Catalysts & Weekly Chart Analysis and Guides - Newser
What technical models suggest about Celcuity Inc.’s comebackMarket Trend Review & Reliable Entry Point Alerts - Newser
What recovery options are there for Celcuity Inc.Insider Selling & Weekly High Return Stock Opportunities - Newser
Celcuity’s Gedatolisib Gains Momentum with FDA’s RTOR Program and Promising Phase 3 Trial Results - TipRanks
Celcuity to initiate gedatolisib NDA submission - TipRanks
Is this a good reentry point in Celcuity Inc.Long Setup & Accurate Entry/Exit Alerts - Newser
Celcuity Inc. shares rise 13.07% after-hours after FDA accepted NDA review for gedatolisib in HR+/HER2- advanced breast cancer. - AInvest
Celcuity to Initiate NDA Submission of Gedatolisib in - GlobeNewswire
Celcuity Gets US FDA Acceptance for NDA Review of Breast Cancer Drug Candidate - MarketScreener
Published on: 2025-08-27 15:43:45 - Newser
How to forecast Celcuity Inc. trends using time seriesBuy Signal & High Accuracy Buy Signal Tips - Newser
Will Celcuity Inc. continue its uptrendWeekly Stock Analysis & Daily Price Action Insights - Newser
Top chart patterns to watch in Celcuity Inc.Weekly Volume Report & Real-Time Volume Analysis Alerts - Newser
How hedge fund analytics apply to Celcuity Inc. stockQuarterly Growth Report & Free Safe Capital Growth Stock Tips - Newser
Is it time to cut losses on Celcuity Inc.Portfolio Growth Summary & Capital Efficiency Focused Ideas - Newser
Does Celcuity Inc. show high probability of reboundTreasury Yields & AI Powered Trade Plan Recommendations - Newser
How to build a custom watchlist for Celcuity Inc.Trend Reversal & Low Risk Entry Point Guides - Newser
What momentum shifts mean for Celcuity Inc.Portfolio Value Summary & Low Risk Entry Point Tips - Newser
Heatmap analysis for Celcuity Inc. and competitors2025 Geopolitical Influence & Stepwise Swing Trade Plans - Newser
Is it time to cut losses on Celcuity IncJuly 2025 Outlook & Short-Term High Return Strategies - Newser
Understanding Celcuity Inc.’s price movementEarnings Overview Report & Daily Profit Maximizing Trade Tips - Newser
Celcuity price target raised to $66 from $50 at H.C. Wainwright - MSN
Applying big data sentiment scoring on Celcuity Inc.Portfolio Return Summary & Safe Entry Zone Identification - Newser
Celcuity Inc. Recovers — But Is It Sustainable2025 Year in Review & Growth-Oriented Investment Plans - newsyoung.net
How to recover losses in Celcuity Inc. stockWeekly Volume Report & Verified Stock Trade Ideas - Newser
Will earnings trigger a reversal in Celcuity Inc.Weekly Trading Summary & Long-Term Investment Growth Plans - Newser
Finanzdaten der Celcuity Inc-Aktie (CELC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.47%
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):